Nicolás Merchante

4.3k total citations
64 papers, 1.4k citations indexed

About

Nicolás Merchante is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Nicolás Merchante has authored 64 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Hepatology, 48 papers in Epidemiology and 17 papers in Infectious Diseases. Recurrent topics in Nicolás Merchante's work include Liver Disease Diagnosis and Treatment (44 papers), Hepatitis C virus research (44 papers) and Liver Disease and Transplantation (17 papers). Nicolás Merchante is often cited by papers focused on Liver Disease Diagnosis and Treatment (44 papers), Hepatitis C virus research (44 papers) and Liver Disease and Transplantation (17 papers). Nicolás Merchante collaborates with scholars based in Spain, United States and Chile. Nicolás Merchante's co-authors include Juan A. Pineda, Juan Macı́as, Antonio Rivero, José Antonio López Mira, Jesús Gómez‐Mateos, José Ángel García-García, Fernando Lozano, Antonio Rivero‐Juárez, Dolores Merino and Francisco Téllez and has published in prestigious journals such as PLoS ONE, Hepatology and Clinical Infectious Diseases.

In The Last Decade

Nicolás Merchante

64 papers receiving 1.3k citations

Peers

Countries citing papers authored by Nicolás Merchante

Since Specialization

Citations

This map shows the geographic impact of Nicolás Merchante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolás Merchante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolás Merchante more than expected).

Fields of papers citing papers by Nicolás Merchante

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolás Merchante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolás Merchante. The network helps show where Nicolás Merchante may publish in the future.

Co-authorship network of co-authors of Nicolás Merchante

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolás Merchante. A scholar is included among the top collaborators of Nicolás Merchante based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolás Merchante. Nicolás Merchante is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Role of rectal colonization by third-generation cephalosporin-resistant Enterobacterales on the risk of surgical site infection after hepato-pancreato-biliary surgery 2024 ·Microbiology Spectrum ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Eva León, (unknown), Pablo Parra-Membríves, Nicolás Merchante	1
2	Early Use of Sarilumab in Patients Hospitalized with COVID-19 Pneumonia and Features of Systemic Inflammation: the SARICOR Randomized Clinical Trial 2022 ·idUS (Universidad de Sevilla) ·Nicolás Merchante, Sheila Cárcel, (unknown), (unknown), (unknown), Rafael León‐López, (unknown), Julián Torre‐Cisneros	25
3	Impact of COVID19 pandemic on the incidence of health-care associated Clostridioides difficile infection 2022 ·Anaerobe ·Nicolás Merchante, (unknown), (unknown), (unknown), Rocío Herrero, Pilar González-de-la-Aleja, Ana Isabel Aller, Juan Carlos Rodrı́guez, (unknown), José Manuel Ramos, (unknown), Esperanza Merino	9
4	Recommendations for the diagnosis and treatment of Clostridioides difficile infection: An official clinical practice guideline of the Spanish Society of Chemotherapy (SEQ), Spaish Society of Internal Medicine (SEMI) and the working group of Postoperative Infection of the Spanish Society of Anesthesia and Reanimation (SEDAR) 2020 ·Revista Española de Quimioterapia ·(unknown), Emilio Bouza, José María Aguado, Luís Alcalá, Benito Almirante, (unknown), (unknown), Javier Cobo, Jordi Guardiola, Juan Pablo Horcajada, Emilio Maseda, Josep Mensa, Nicolás Merchante, Patricia Muñóz, (unknown), Miquel Pujol, Elena Reigadas, Miguel Salavert, José Barberán	15
5	Efficacy and safety of early treatment with sarilumab in hospitalised adults with COVID-19 presenting cytokine release syndrome (SARICOR STUDY): protocol of a phase II, open-label, randomised, multicentre, controlled clinical trial 2020 ·BMJ Open ·Rafael León‐López, (unknown), (unknown), Alberto Romero-Palacios, (unknown), (unknown), (unknown), Jesús Rodríguez‐Baño, Nicolás Merchante, Julián Olalla, (unknown), (unknown), (unknown), Julián Torre‐Cisneros	10
6	Baseline resistance-guided therapy does not enhance the response to interferon-free treatment of HCV infection in real life 2018 ·Scientific Reports ·Luís Miguel Real, Juan Macı́as, Ana Belén Pérez, Dolores Merino, Rafael Granados, Luís Morano, Marcial Delgado, María Rios, Carlos Galera, Miguel García Deltoro, Nicolás Merchante, Féderico García, Juan A. Pineda	3
7	Rotavirus VP6 protein mucosally delivered by cell wall-derived particles from Lactococcus lactis induces protection against infection in a murine model 2018 ·PLoS ONE ·(unknown), Marcelo H. Argüelles, Nicolás Merchante, Patricia A. Barril, (unknown), (unknown), (unknown), Graciela Glikmann, Alejandro A. Castello	11
8	Similar recovery of liver function after response to all‐oral HCV therapy in patients with cirrhosis with and without HIV coinfection 2018 ·Journal of Viral Hepatitis ·Juan Macı́as, Rafael Granados, Francisco Téllez, Dolores Merino, (unknown), Luís Morano, Rosario Palacios, María Paniagua, Mario Frías, Nicolás Merchante, Juan A. Pineda, (unknown)	10
9	Executive summary: Consensus document of GEHEP of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), along with SOCIDROGALCOHOL, SEPD and SOMAPA on hepatitis C virus infection management in drug users 2018 ·Enfermedades Infecciosas y Microbiología Clínica ·Juan A. Pineda, (unknown), Féderico García, Miguel García Deltoro, Rafael Granados, (unknown), Juan Macı́as, Álvaro Mena, Nicolás Merchante, Enriqueta Ochoa Mangado, Carlos Roncero, Juan Jesús Ruiz, Francisco Téllez, Luís Morano	9
10	Bacterial translocation and clinical progression of HCV‐related cirrhosis in HIV‐infected patients 2017 ·Journal of Viral Hepatitis ·Nicolás Merchante, Teresa Aldámiz‐Echevarría, Mónica García–Álvarez, (unknown), Juan Macı́as, Pilar Miralles, María Ángeles Jiménez‐Sousa, M.J. Mancebo, Leire Pérez‐Latorre, Daniel Pineda‐Tenor, Juan Berenguer, Salvador Resino, Juan A. Pineda	5
11	Real-life experience with sorafenib for the treatment of hepatocellular carcinoma in HIV-infected patients 2016 ·AIDS ·Nicolás Merchante, Sofía Ibarra, Boris Revollo, Francisco Rodríguez-Arrondo, Esperanza Merino, (unknown), Marta Montero, Francisco Téllez, Marı́a José Galindo, Antonio Rivero‐Juárez, (unknown), (unknown), Alberto Romero-Palacios, Miguel García Deltoro, Juan A. Pineda	12
12	Hepatitis C virus reinfection after sustained virological response in HIV-infected patients with chronic hepatitis C 2015 ·Journal of Infection ·Juan A. Pineda, Rocío Núñez‐Torres, Francisco Téllez, M.J. Mancebo, Féderico García, Nicolás Merchante, (unknown), Karin Neukam, Juan Macı́as, Luís Miguel Real	39
13	Impact of HIV infection on sustained virological response to treatment against hepatitis C virus with pegylated interferon plus ribavirin 2015 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown), (unknown), Ángeles Castro‐Iglesias, Antonio Rivero‐Juárez, Francisco Javier Martínez‐Marcos, (unknown), Luís Miguel Real, Berta Pernas, Nicolás Merchante, (unknown), Juan Macı́as, (unknown), Antonio Rivero, Álvaro Mena, Karin Neukam, Juan A. Pineda	8
14	Incidence and natural history of hepatitis E virus coinfection among HIV-infected patients 2014 ·AIDS ·Juan A. Pineda, Celia Cifuentes, Manuel Parra, Nicolás Merchante, (unknown), Antonio Rivero‐Juárez, (unknown), Antonio Rivero, Juan Macı́as, Luís Miguel Real	44
15	Increasing Incidence of Hepatocellular Carcinoma in HIV-Infected Patients in Spain 2012 ·Clinical Infectious Diseases ·Nicolás Merchante, Esperanza Merino, José López-Aldeguer, Francisco Jover, (unknown), María José Galindo, Enrique Ortega, Antonio Rivero, (unknown), Alberto Romero-Palacios, Sergio Padilla, Manuel Márquez, Concha Amador, Maria José Ríos-Villegas, Francisco Téllez, Joaquín Portilla, Juan A. Pineda	51
16	Liver Toxicity of Antiretroviral Combinations Including Fosamprenavir Plus Ritonavir 1400/100 mg Once Daily in HIV/Hepatitis C Virus-Coinfected Patients 2011 ·AIDS Patient Care and STDs ·Nicolás Merchante, Luís F. López‐Cortés, (unknown), Maria José Ríos-Villegas, Manuel Márquez, Dolores Merino, Juan Pasquau, (unknown), (unknown), Mohamed Omar, Antonio Rivero, Juan Macı́as, Rosario Mata, Juan A. Pineda	7
17	Efficacy of chronic hepatitis C therapy with pegylated interferon and ribavirin in patients on methadone maintenance treatment 2011 ·European Journal of Clinical Microbiology & Infectious Diseases ·Karin Neukam, (unknown), (unknown), (unknown), María J. Vázquez, Celia Cifuentes, (unknown), Nicolás Merchante, C. Almeida, Juan Macı́as, Juan A. Pineda	6
18	Low-level liver enzyme elevations during HAART are not associated with liver fibrosis progression among HIV/HCV-coinfected patients 2006 ·Journal of Antimicrobial Chemotherapy ·(unknown), Juan Macı́as, (unknown), José Ángel García-García, Nicolás Merchante, José del Valle, Laila Abdel‐Kader Martín, Fernando Lozano, Jesús Gómez‐Mateos, Juan A. Pineda	4
19	Increased Hepatocyte Fas Expression and Apoptosis in HIV and Hepatitis C Virus Coinfection 2005 ·The Journal of Infectious Diseases ·Juan Macı́as, Miguel Á. Japón, Carmen Sáez, (unknown), José Antonio López Mira, José Ángel García-García, Nicolás Merchante, (unknown), Fernando Lozano, Jesús Gómez‐Mateos, Juan A. Pineda	33
20	Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C 2004 ·AIDS ·Juan Macı́as, V. Castellano, Nicolás Merchante, (unknown), José Antonio López Mira, Carmen Sáez, José Ángel García-García, Fernando Lozano, Jesús Gómez‐Mateos, Juan A. Pineda	128

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact